Tuesday, November 12, 2019
- 4:30PM-6:00PM
-
Abstract Number: 2809
Single-Cell RNA Sequencing of Murine Neutrophils Identifies a Transcriptional Continuum (“Neutrotime”) Across Biological Compartments
5T110: Innate Immunity (2804–2809)- 4:30PM-6:00PM
-
Abstract Number: 2847
Testing Different Thresholds for Patient Global Assessment in Defining ACR-EULAR Boolean Remission Criteria for RA
5T114: RA – Diagnosis, Manifestations, & Outcomes IV: Outcomes (2846–2851)- 4:30PM-6:00PM
-
Abstract Number: 2838
The First Phase 2a Proof-of-Concept Study of a Selective NLRP3 Inflammasome Inhibitor, Dapansutrile™ (OLT1177™), in Acute Gout
5T112: Metabolic & Crystal Arthropathies II: Genetics & Physiology (2834–2839)- 4:30PM-6:00PM
-
Abstract Number: 2811
The IRE1α Pathway Mediates Neutrophil Stress and NETosis in Lupus
5T115: SLE – Etiology & Pathogenesis I: Signaling Pathways (2810–2815)- 4:30PM-6:00PM
-
Abstract Number: 2853
The Pattern of Musculoskeletal Complaints in Patients with Suspected Psoriatic Arthritis and Their Correlation with Physical Examination and Ultrasound
5T116: Spondyloarthritis Including Psoriatic Arthritis – Clinical VI: Psoriatic Arthritis Clinical Studies (2852–2857)- 4:30PM-6:00PM
-
Abstract Number: 2819
The Transcription Factor MAF Controls the Ability of T Peripheral Helper (Tph) Cells to Help B Cells
5T117: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2816–2821)- 4:30PM-6:00PM
-
Abstract Number: 2830
Treatment Delays Associated with Prior Authorization for Infusible Medications: A Cohort Study
5T111: Measures of Healthcare Quality II: Quality Improvement in Rheumatology – Still Getting Better (2828–2833)- 4:30PM-6:00PM
-
Abstract Number: 2832
Using a Learning Collaborative to Develop an RA Disease Activity Communication Tool to Promote Shared Decision-Making in Treat to Target